393
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Effectiveness of Treatments for Ocular Toxoplasmosis

, MDORCID Icon, , MD, PhDORCID Icon, , PhD, MBAORCID Icon, , MDORCID Icon, , MD, PhDORCID Icon, , MD, PhDORCID Icon, , MD, PhDORCID Icon, , MDORCID Icon, , PhD, MPH, MBAORCID Icon & , MD, PhDORCID Icon show all
Pages 249-255 | Received 17 Aug 2018, Accepted 02 Jan 2019, Published online: 26 Feb 2019

References

  • Gonzalez Fernandez D, Nascimento H, Nascimento C, Muccioli C, Belfort R Jr. Uveitis in São Paulo, Brazil: 1053 new patients in 15 months. Ocul Immunol Inflamm. 2017;25(3):382–387. doi:10.3109/09273948.2015.1132741.
  • Soheilian M, Heidari K, Yazdani S, Shahsavari M, Ahmadieh H, Dehghan M. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm. 2004;12(4):297–310. doi:10.1080/092739490500174.
  • Perkins ES, Schofield PB, Smith CH. Treatment of uveitis with pyrimethamine (daraprim). Br J Ophthalmol. 1956;40(10):577–586. doi:10.1136/bjo.40.10.577.
  • Burnett AJ, Shortt SG, Isaac-Renton J, King A, Werker D, Bowie WR. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology. 1998;105(6):1032–1037. doi:10.1016/S0161-6420(98)96004-3.
  • Park YH, Nam HW. Clinical features and treatment of ocular toxoplasmosis. Korean J Parasitol. 2013;51(4):393–399. doi:10.3347/kjp.2013.51.4.393.
  • Commodaro AG, Belfort RN, Rizzo LV, et al. Ocular toxoplasmosis: an update and review of the literature. Mem Inst Oswaldo Cruz. 2009;104(2):345–350.doi:10.1590/S0074-02762009000200030.
  • Rothova A, Buitenhuis HJ, Meenken C, et al. Therapy of ocular toxoplasmosis. Int Ophthalmol. 1989;13(6):415–419.doi:10.1007/BF02306491.
  • Soheilian M, Ramezani A, Azimzadeh A, et al. Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. Ophthalmology. 2011;118(1):134–141.doi:10.1016/j.ophtha.2010.04.020.
  • Novais EA, Commodaro AG, Santos F, et al. Patients with diffuse uveitis and inactive toxoplasmic retinitis lesions test PCR positive for Toxoplasma gondii in their vitreous and blood. Br J Ophthalmol. 2014;98(7):937–940.doi:10.1136/bjophthalmol-2013-304184.
  • Lima GS, Saraiva PG, Saraiva FP. Current therapy of acquired ocular toxoplasmosis: a review. J Ocul Pharmacol Ther. 2015;31(9):511–517. doi:10.1089/jop.2015.0059.
  • Wakefield D, Cunningham ET Jr., Pavesio C, Garweg JG, Zierhut M. Controversies in ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19(1):2–9. doi:10.3109/09273948.2011.547157.
  • Soheilian M, Sadoughi MM, Ghajarnia M, et al. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology. 2005;112(11):1876–1882.doi:10.1016/j.ophtha.2005.05.025.
  • Slatore CG, Tilles SA. Sulfonamide hypersensitivity. Immunol Allergy Clin North Am. 2004;24(3):477–490. vii. doi:10.1016/j.iac.2004.03.011.
  • Centers for Disease Control and Prevention. Parasites - Toxoplasmosis (Toxoplasma infection). Treatment. https://www.cdc.gov/parasites/toxoplasmosis/health_professionals/index.html. Published April 10, 2017. Accessed August 12, 2018.
  • Kim SJ, Scott IU, Brown GC, et al. Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology. Ophthalmology. 2013;120(2):371–378.doi:10.1016/j.ophtha.2012.07.061.
  • Garweg JG, Stanford MR. Therapy for ocular toxoplasmosis: the future. Ocul Immunol Inflamm. 2013;21(4):300–305. doi:10.3109/09273948.2013.779724.
  • Silveira C, Belfort R Jr., Muccioli C, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 2002;134(1):41–46.doi:10.1016/S0002-9394(02)01527-1.
  • Silveira C, Muccioli C, Nussenblatt R, Belfort R Jr. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis: 10 years of follow-up. Ocul Immunol Inflamm. 2015;23(3):246–247. doi:10.3109/09273948.2014.964422.
  • Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev. 2018;31(4). doi:10.1128/CMR.00057-17.
  • Pradhan E, Bhandari S, Gilbert RE, Stanford M. Antibiotics versus no treatment for toxoplasma retinochoroiditis. Cochrane Database Syst Rev. 2016;5:CD002218. doi:10.1002/14651858.CD002218.pub2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.